SSc research survey from Michael Macklin | University of Chicago |

Replies
0
Voices
1
Cecile Bremont
Cecile Bremont

Note: link to the survey https://redcap.uchicago.edu/surveys/?s=D97TYC4XRHPMRDE4 Dear Members of EUSTAR, We are aiming to evaluate the safety and effectiveness of mycophenolate vs tocilizumab/mycophenolate (TCZ/MMF) combination therapy in systemic sclerosis-associated interstitial lung disease. As part of…

View Topic

juvenile systemic scleroderma

Replies
1
Voices
2
Ivan Foeldvari
Ivan Foeldvari

I would like to invite centers, who are following patients under the age of 18 to include this patients in juvenile scleroderma inception cohort- www.juvenile-scleroderma.com or contact me at sprechstunde@kinderrheumatologie.de best regards Ivan Foeldvari

View Topic

Application to improve EUSTAR data base

Replies
1
Voices
2
Gabriela Riemekasten
Gabriela Riemekasten

As we have discussed in the meeting in London, Centers can apply to improve the quality of the EUSTAR data bank. Deadline was set in Septeber. Since I did not find an application form and…

View Topic

EUSTAR Couse

Replies
1
Voices
2
Ivan Foeldvari
Ivan Foeldvari

I would propose, that we have a pediatric part in the EUSTAR Course Best regards Ivan Foeldvari

View Topic